WARP DRIVE BIO, LLC
Biotech · Acquired
Natural product genome mining platform to discover novel beta-lactam antibiotics from actinomycete gene clusters
warpdrivebio.com →- Grants
- $1.4M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 5 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Novel, Specific, and Sensitive Mass Spectrometry-Based Protein-Ligand Binding Assay to Discover Novel Beta-Lactam Antibiotics | $225,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Genome Mining the Full Diversity of the Actinomycete Biosynthetic Universe for Neomorph Antibiotic Discovery | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Genome Mining the Full Diversity of the Actinomycete Biosynthetic Universe for Neomorph Antibiotic Discovery | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Harnessing Genomic Information to Engineer Combinatorial Biosynthesis of a Large Polyketide Natural Products Library | $209,559 | |
| Federal grant | Department of Health and Human Services · Phase I · Harnessing Genomic Information to Engineer Combinatorial Biosynthesis of a Large Polyketide Natural Products Library | $209,559 | |
| Federal grant | Department of Health and Human Services · Phase I · New Approaches to Mining the Complete Actinomycete Genome to Discover Novel Beta-Lactam Antibiotics | $154,588 | |
| Federal grant | Department of Health and Human Services · Phase I · New Approaches to Mining the Complete Actinomycete Genome to Discover Novel Beta Lactam Antibiotics | $154,588 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3022 | Nitrase Therapeutics | — | — |
| 3023 | EASCRA BIOTECH, INC. | — | — |
| 3024 | Draig Therapeutics | — | — |
| 3025 | WARP DRIVE BIO, LLC | — | — |
| 3026 | Artios | — | — |
| 3027 | Montai Therapeutics | — | — |
| 3028 | Parabricks Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For The Production Of Compoundsgranted
- Methods And Reagents For Analyzing Protein-protein Interfacesgranted
- Identifying New Therapeutic Agentsgranted
- Compounds That Participate In Cooperative Binding And Uses Thereofgranted
- Methods And Reagents For Analyzing Protein-protein Interfacesgranted
- Methods And Reagents For Analyzing Protein-protein Interfacesapplication
- Compositions And Methods For The Production Of Compoundsapplication
- Compositions And Methods For The Production Of Compoundsapplication
- Compositions And Methods For The Production Of Compoundsapplication
- Compositions And Methods For The Production Of Compoundsapplication
- Compounds That Participate In Cooperative Binding And Uses Thereofapplication
- Compounds That Participate In Cooperative Binding And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.